← Back to Search

Biologic Mesh

Fortiva vs Strattice Mesh for Hernia Repair

N/A
Recruiting
Led By Todd Heniford, MD
Research Sponsored by Wake Forest University Health Sciences
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year follow up post surgical repair
Awards & highlights

Study Summary

This trial is comparing the recurrence rates and complications of two different types of hernia repair mesh.

Who is the study for?
This trial is for individuals who need surgery to repair a ventral hernia, which is a bulge of tissues through an opening within abdominal muscles. Pregnant women are not eligible to participate.Check my eligibility
What is being tested?
The study compares two types of mesh used in hernia repair surgeries: Fortiva and Strattice. It looks at how often the hernia comes back after using each mesh and what complications might arise with each type.See study design
What are the potential side effects?
While specific side effects aren't listed, common ones from hernia mesh may include pain, infection, hernia recurrence, adhesion (tissue sticking together), and possible allergic reactions.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year follow up post surgical repair
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year follow up post surgical repair for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Frequency of participants with a Hernia recurrence
Percent of participants with a Hernia recurrence
Secondary outcome measures
Frequency of participants with a Mesh related complication
Percent of participants with a Mesh related complication

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: ProspectiveExperimental Treatment1 Intervention
Participants enrolled to ventral hernia repair with Fortiva mesh
Group II: RetrospectiveActive Control1 Intervention
Retrospective participants with ventral hernia repair using Strattice mesh

Find a Location

Who is running the clinical trial?

Wake Forest University Health SciencesLead Sponsor
1,243 Previous Clinical Trials
1,004,530 Total Patients Enrolled
Todd Heniford, MDPrincipal InvestigatorWake Forest University Health Sciences
5 Previous Clinical Trials
908 Total Patients Enrolled

Media Library

Fortiva (Biologic Mesh) Clinical Trial Eligibility Overview. Trial Name: NCT05572021 — N/A
Ventral Hernia Research Study Groups: Prospective, Retrospective
Ventral Hernia Clinical Trial 2023: Fortiva Highlights & Side Effects. Trial Name: NCT05572021 — N/A
Fortiva (Biologic Mesh) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05572021 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Could I potentially partake in this research endeavor?

"This study is inviting 200 individuals of ages 18 to 100 with confirmed ventral hernias for surgery. Qualified applicants must have a recognised need for surgical repair due to their affliction."

Answered by AI

What are the objectives of this experiment?

"The main goal of this surgical trial, which will be measured over the course of a year post-repair, is to assess hernia recurrence rate. Additionally, researchers are evaluating mesh-associated complications frequency and prevalence."

Answered by AI

Are octogenarians eligible for this research experiment?

"This clinical trial is seeking patients aged between 18 and 100, with 16 studies for younger individuals and 134 for those beyond 65 years old."

Answered by AI

Are there any openings for participation in this trial at present?

"Reports hosted on clinicaltrials.gov suggest that this medical trial is not presently seeking patients; the study was initially posted January 1st 2023 and last updated October 7th 2022. Although it is inactive, there are 160 other trials actively recruiting participants currently."

Answered by AI
~112 spots leftby Feb 2025